Skip to main content
. 2017 Sep 15;8(52):89465–89474. doi: 10.18632/oncotarget.20948

Figure 2. Confirmation of ALK rearrangement using immunohistochemistry and fluorescent in situ hybridization analysis.

Figure 2

A. All ALK-rearranged inflammatory myofibroblastic tumors display diffusely strong granular cytoplasmic expression of ALK during immunohistochemistry. B. Split signals confirm the presence of ALK rearrangement.